| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d7dfd84f9157ae12c41e319ec325338d |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-555
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-57
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08 |
| filingDate |
1986-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3dba19a63bab1c40a470c47474677bc5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19f0d59e1542ec3a5d716bece5560454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10ad2745e268aa06c11a07413d158d2a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_99b237d15751c08fbc091d1485ae0d05 |
| publicationDate |
1988-06-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
JP-S63142000-A |
| titleOfInvention |
Monoclonal antibody |
| abstract |
NEW MATERIAL:A monoclonal antibody reactive with natural and recombinant interferon-gamma and nonreactive with interferon-gamma decomposed by cyanogen bromide and/or pepsin. USE:A reagent for purification and quantitative determination of interferon-gamma. PREPARATION:A BALB/C mouse is administered and immunized with a non- glycosylated interferon-gamma. Spleen cell is extracted from the mouse and subjected to cell fusion with a mouse myeloma cell using polyethylene glycol to obtain a hybridoma. The hybridoma is screened to select a clone reactive with non- glycosylated interferon-gamma and cloned by limiting dilution analysis and the obtained monoclonized product is cultured to obtain the objective monoclonal antibody. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7582445-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8557967-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7910707-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8349331-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7087726-B2 |
| priorityDate |
1986-12-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |